The global home dialysis systems market size was valued at USD 17.56 billion in 2021. It is projected to reach USD 47.32 billion by 2030, growing at a CAGR of 10.42% during the forecast period (2022–2030).
Hemodialysis is a treatment that removes waste and excess fluid from the blood in place of the kidneys. This is accomplished with the aid of a specific filter known as a dialyzer or artificial kidney.
Blood is transported to the dialyzer through plastic tubing, where it is purified and then returned. Dialysis is a procedure used to eliminate waste products from the blood, such as urea and creatinine, in patients with chronic renal failure who have impaired kidney function. Necessary for the treatment of end-stage renal disease (ESRD) and kidney transplants. This technique purifies the blood, removes extra fluid and contaminants, and restores electrolyte balance. There are two methods for performing dialysis: hemodialysis and peritoneal dialysis. In hemodialysis, waste materials such as urea are removed from the patient's extracorporeal blood. The peritoneum is the abdomen utilized for dialysis in peritoneal dialysis.
The market expansion is attributable to technological improvements, dangers involved with transplants, increased frequency of chronic renal illnesses, endeavors by the major players to introduce enhanced products and services, and a lack of organ donors. Outset Medical, Inc., a medical technology company whose mission is to reduce the complexity and cost of dialysis, joined Health Home, an alliance of innovative healthcare firms whose mission is to alter policymakers' view of home diagnosis fundamentally. They want to convince policymakers to reevaluate the home as a clinical treatment facility for managing chronic diseases through cooperation in the healthcare sector. These actions are expected to cause the market to grow soon.
Demand for dialysis therapy is expected to increase as the prevalence of ESRD continues to rise worldwide. Every single year, ESRD affects around 2 million people all over the world. It is projected that the progression of renal disorders worldwide would increase the need for dialysis to preserve normal kidney functioning. It is anticipated that the prevalence of kidney-related disorders will dramatically increase due to the rapid growth in the global population of older people.
Cardiac diseases and vascular-related complications such as bleeding and infection, low blood pressure, nausea, hernia, hepatitis, and anemia are the primary causes of mortality among dialysis patients. Other complications include circulatory disease (arrhythmic mechanisms or sudden cardiac arrest). Peritonitis is a common complication that can arise from peritoneal dialysis. It can be brought on by the contamination of peritoneal dialysate or tubing with bacteria that are harmful to the skin, or it can be brought on by infections associated with catheters. Each year in North America, around 19% of patients being treated for PD pass away due to peritonitis. Because of this, the number of people undergoing dialysis is restricted.
China, India, and Mexico are anticipated to provide substantial growth possibilities for hemodialysis and peritoneal dialysis participants. According to the US Renal Data System, Taiwan and Malaysia had the most significant incidence of treated ESRD in the 45–65 and 75 age groups, respectively. Players are increasingly concentrating on implementing strategic developments to increase their presence in these markets and tap a sizable customer base to take advantage of the significant growth opportunities in emerging nations. In addition, government financing for the treatment of ESRD, the development of home/nocturnal dialysis, and the increase in the number of dialysis clinics all contribute to the expansion of dialysis treatments in developing nations.
| Study Period | 2018-2030 | CAGR | 10.42% |
| Historical Period | 2018-2020 | Forecast Period | 2022-2030 |
| Base Year | 2021 | Base Year Market Size | USD 17.56 Billion |
| Forecast Year | 2030 | Forecast Year Market Size | USD 47.32 Billion |
| Largest Market | North America | Fastest Growing Market | Asia-Pacific |
The global home dialysis systems market is segmented into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
North America is the most dominant in the global home dialysis systems market during the forecast period. Significant government investments in the creation of novel medical devices, prominent market participants, and a good reimbursement environment all contribute to the expansion of the regional market. As the prevalence of chronic kidney disease (CKD) rises, so does the need for home dialysis. Increasing healthcare expenditures, a high disposable income, and government initiatives are a few significant contributors to the market's growth. Innovate Kidney Care's mission is to achieve the triple objective of improved patient outcomes, enhanced health care practitioner experiences, enhanced patient experiences, and decreased healthcare costs.
Asia-Pacific is projected to undergo the highest CAGR during the projection period. The growing elderly population, the escalating incidence of kidney failure, and the increased development of innovative products are anticipated to drive market expansion. In addition, according to the IDF, around 88 million adults in Southeast Asia have diabetes which is anticipated to rise to 153 million by 2045. In addition, government initiatives, rising healthcare expenditures, increased awareness campaigns regarding chronic kidney disease (CKD), and the presence of newly-established, state-of-the-art healthcare facilities in the region all contribute to market expansion.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global home dialysis systems market is segmented by Type, Product, and Treatment.
Based on type, the market is segmented into hemodialysis and peritoneal dialysis.
The hemodialysis (HD) segment will dominate the market during the forecast period. Hemodialysis is the most prevalent form of treatment for chronic renal disease. They consist of machines, dialyzers, bloodlines, hemodialysis solutions and concentrates, water treatment systems, and data processing and analysis systems. The category is anticipated to expand due to several factors, including the rising frequency of acute renal injury and technological advances. After hemodialysis, peritoneal dialysis (PD) is the second-leading category. Home systems and supplies for continuous peritoneal dialysis and automated peritoneal dialysis are available from various manufacturers.
Based on product, the market is segmented into devices, consumables, and services.
The service segment holds a significant market share due to an increase in the number of dialysis service providers and the prevalence of ESRD. In addition, several large dialysis service providers are attempting to expand their service offerings by opening or acquiring new dialysis facilities around the globe, which is anticipated to contribute to segment growth. As a result of technology advancements and numerous manufacturers' activities, the industry is anticipated to expand even more rapidly. The consumables section is anticipated to grow fastest over the projection period. During the projection period, governments are anticipated to make substantial investments to enhance patient safety, patient-centered care, and efficacy. Companies are developing catheters made of sophisticated materials resistant to substances such as peroxides, iodine, and alcohol.
Based on treatment, the market is segmented into Acute Kidney Disease and Chronic Kidney Disease.
Chronic renal disease dominates the market with the highest revenue share. ESRD is diagnosed when a patient's kidneys no longer work well enough to prevent a fatal buildup of fluid and toxins. Chronic disorders such as hypertension and diabetes are the most prevalent causes. The prevalence of kidney failure is projected to increase to one million persons by 2030 due to multiple preexisting conditions and demographic factors such as diabetes, hypertension, obesity, and an aging population.
